-+ 0.00%
-+ 0.00%
-+ 0.00%

Alvotech Wins FDA Approval for Simlandi Process That More Than Doubles Output per Batch

PUBT·10/20/2026 08:32:01
Alvotech Wins FDA Approval for Simlandi Process That More Than Doubles Output per Batch
  • Alvotech received FDA approval for a Simlandi manufacturing process that more than doubles drug substance output per batch.
  • Process 2.0 will operate in the DSM2 manufacturing suite in Reykjavik, Iceland, without increasing upstream manufacturing scale.
  • Process development and validation demonstrated comparability with the previously approved process, maintaining product quality, safety and efficacy.
  • Higher batch output frees manufacturing capacity for other portfolio products, improving flexibility to meet growing demand.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alvotech SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610200430PRIMZONEFULLFEED1001278803) on October 20, 2026, and is solely responsible for the information contained therein.